Live tape
Top 8, mentions 7d17,441MSFT3,294 mentions▲ +0.08GOOGL2,668 mentions▲ +0.05AAPL2,263 mentions▲ +0.07META2,220 mentions▲ +0.04SPCX1,991 mentions▲ +0.06SNDK1,836 mentions▲ +0.06NVDA1,748 mentions▲ +0.07QQQ1,421 mentions▲ +0.04

Equity · Healthcare

BDX

Becton, Dickinson and Company · NYSE

$166.00 +4.40% 1D Finazon · prior-day close · Jul 28, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of BDX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 63 sessions over that window: $149.35 on 1 May 2026 through $166.00 on 28 July 2026. Finazon · prior-day close.

Market cap $45.7B
P/E (TTM) 50.3
52-week range $140.68 – $210.09
Avg volume 462.2K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

BDX insider trades

SEC Form 4 · last 90 days · newest reported trade 27 Jul 2026
Open-market buys 0
Open-market sells 6
Net sold $766K
Non-trade filings 6
Date Insider Type Shares Value
27 Jul 2026 Feld Michael EVP, Chief Revenue Officer Sell 75 $12K
26 Jun 2026 Feld Michael EVP, Chief Revenue Officer Sell 75 $11K
24 Jun 2026 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sell 1,100 $160K
10 Jun 2026 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sell 1,100 $167K
01 Jun 2026 Polen Thomas E Jr Chairman, CEO and President Sell 2,764 $405K
26 May 2026 Feld Michael EVP, Chief Revenue Officer Sell 75 $11K
Compensation mechanics (6 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Jul 2026 Muhsin Bilal EVP & President Connected Care Tax withheld 1,935
01 Jul 2026 Muhsin Bilal EVP & President Connected Care Award 14,342
01 Jun 2026 Polen Thomas E Jr Chairman, CEO and President Option exercise 20,209 $2.55M
01 Jun 2026 Polen Thomas E Jr Chairman, CEO and President Other 17,445 $2.55M
01 Jun 2026 Menziuso Peter EVP and President, BDI Award 14,258
07 May 2026 Roque Vitor EVP & Chief Financial Officer Award 1,721

BDX reported financials

SEC EDGAR XBRL

BDX reported revenue of $21.8B for the fiscal year ended 30 Sep 2025. Net income over the same period was $1.7B.

Figure Reported Period
Revenue $21.8B 30 Sep 2025 fiscal year
Net income $1.7B 30 Sep 2025 fiscal year
Diluted EPS $5.82 30 Sep 2025 fiscal year
Total assets $50.8B 31 Mar 2026 at period end
Total equity $24.1B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

BDX earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q2 2026 $-1.11 $4.71B
31 Dec 2025 Q1 2026 $1.34 $5.25B
30 Sep 2025 FY 2025 $5.82 $21.84B
30 Jun 2025 Q3 2025 $2.00 $5.51B

Reported figures & scheduled dates · SEC EDGAR filings

BDX institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a BDX position for the quarter ended 31 Mar 2026 — a combined $641.3M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Marshall Wace Held (±25%) +9.0% shares 1,587,797 $249.6M
Citadel Advisors Added +61.8% shares 829,501 $130.4M
AQR Capital Management Trimmed −36.1% shares 757,930 $118.6M
Starboard Value Trimmed −31.6% shares 636,494 $100.1M
Millennium Management Added +297.5% shares 179,296 $28.2M
Two Sigma Investments Held (±25%) 36,559 $5.7M
Tudor Investment Corp New position 17,285 $2.7M
Man Group Held (±25%) −1.7% shares 14,165 $2.2M
Bridgewater Associates Held (±25%) +5.1% shares 9,496 $1.5M
GAMCO Investors Held (±25%) +0.1% shares 9,481 $1.5M

Source: SEC EDGAR 13F filings

BDX fails-to-deliver

SEC CNS data

On 30 Jun 2026, 63,258 shares of BDX failed to deliver (about $9.8M) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Jun 2026 63,258 $9.8M 0.023%
29 Jun 2026 111,293 $17.4M 0.040%
23 Jun 2026 61 $9K <0.001%
22 Jun 2026 4,874 $702K 0.002%
16 Jun 2026 4,745 $690K 0.002%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in BDX

STOCK Act disclosures

The most recent congressional trade disclosed in BDX is a sale by Thomas H. Kean, Jr. (house, NJ), dated 21 May 2026.

Date Member Type Amount
21 May 2026 filed 18 Jun 2026 Thomas H. Kean, Jr. house · Republican–NJ Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures